ATAI Life Sciences N.V’s recent filing unveils that its 10% Owner Apeiron Investment Group Ltd. acquired Company’s shares for reported $22.76 million on Feb 14 ’25. In the deal valued at $2.10 per share,10,835,718 shares were bought. As a result of this transaction, Apeiron Investment Group Ltd. now holds 40,555,215 shares worth roughly $80.7 million.
Then, ATAI Life Sciences N.V. sold 2,660,000 shares, generating $16,093,000 in total proceeds. Upon selling the shares at $6.05, the 10% Owner now owns 6,905,774 shares.
Before that, Brand Florian sold 151,303 shares. ATAI Life Sciences N.V shares valued at $290,502 were divested by the insider at a price of $1.92 per share. As a result of the transaction, Brand Florian now holds 328,697 shares, worth roughly $0.65 million.
H.C. Wainwright reiterated its ATAI Life Sciences N.V [ATAI] rating to a Buy in a research note published on November 18, 2024; the price target was $10. A number of analysts have revised their coverage, including Maxim Group’s analysts, who increased its forecast for the stock in early April from “a Hold” to “a Buy”. Loop Capital began covering ATAI with “Buy” recommendation on November 01, 2022. Maxim Group started covering the stock on November 30, 2021. It rated ATAI as “a Buy”.
Price Performance Review of ATAI
On Friday, ATAI Life Sciences N.V [NASDAQ:ATAI] saw its stock fall -2.45% to $1.99. Over the last five days, the stock has lost -12.33%. ATAI Life Sciences N.V shares have risen nearly 49.62% since the year began. Nevertheless, the stocks have fallen -1.00% over the past one year. While a 52-week high of $2.85 was reached on 02/12/25, a 52-week low of $1.03 was recorded on 01/14/25. SMA at 50 days reached $1.6512, while 200 days put it at $1.4615.
Levels Of Support And Resistance For ATAI Stock
The 24-hour chart illustrates a support level at 1.9233, which if violated will result in even more drops to 1.8567. On the upside, there is a resistance level at 2.1033. A further resistance level may holdings at 2.2167. The Relative Strength Index (RSI) on the 14-day chart is 51.96, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1464, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 51.63%. Stochastics %K at 52.86% indicates the stock is a holding.
The most recent change occurred on November 11, 2021 when ROTH Capital began covering the stock and recommended ‘”a Buy”‘ rating along with a $32 price target.
